No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds 2128.
No tracked institution reports a position in 2128 as of their last filing.
No one on the platform has traded 2128 yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
@CatalystInvestments @LTtrader04 Human Genome Sciences ($hgsi) was 48 cents on March 11, 2009 and then bought out for 14.25 by $gsk on July 16, 2012. It should also be noted that it was 33.30 on April 14, 2010 (13 months after being at 48 cents)....
View on StockTwits ↗
$AMRN The end of this study which did not recruit the initial number of subjects ends today. How long will it take before the official press release which will echo these results? Between approximately 1 and 3 months? You see, Intercept has just been bought with a premium of 82% of the last price. I looked, it’s horrible!! I followed Intercept at a time when it was trading at $120!!! when the race to fight against NASH was at its height with "Genfit", a French Biotech (which also failed and went from 70€ at the end of phase II (speculation) to 3$ after the failure of Phase III. J I hope that if AMRN is bought back one day, the same thing won't happen!! I knew AMRN from 3.60 to $24. I traded AMRN from $3.60 to $12. I'm back at 0.9022* $ (I never would have believed this after a 16/0 Panel for Vascepa's approval! lol ( Idem $HGSI ) I am willing to give my shares to Bp at $12 again, but not less! This is the basis . (406 * $12 is only 4.8 billion after all!)
View on StockTwits ↗
@DeepDiamond look up $HGSI, the company that originally owned Benlysta. Had an initial offer for over double what it ended up selling for to $GSK because they thought they would do billions on their own…
View on StockTwits ↗
$SRZN CEO Craig Parker helped sell $HGSI to $GSK back in the day. There is no other logical outcome here aside from a sale, unless they think they can 5x the stock by EOY.
View on StockTwits ↗
$AUPH Wow He said below that “this is going to turn out to be another case of $HGSI”. So, he is 100% sure that AUPH will go to BK. I remember that he was 100% bullish on this and now he is 100% bearish. Hashtagzee is just a f*cking idiot. He is a moron and stupid. Go to H-E-L-L
View on StockTwits ↗
$AUPH $HGSI $GSK Very interesting connection of Habig. For those who have blocked HashtagZ. This is scary. Get up and be ready to dispose PG in EGM otherwise your money is gone in their accounts.
View on StockTwits ↗$AUPH POS Greenleaf has completely hijacked this company. This is going to turn out to be another case of $HGSI SP hit $30, turned down offers in that range and decided to GIA, eventually got taken out by patient BP company $GSK for $14.25 a share. Plot twist: the major drug GSK acquired from Humane Genome Sciences was Benlysta, the only current on-label competitive drug to LUPKYNIS. Plot twist #2: the person in charge for heading Benlysta sales at HGS, Scott Habig, is now overseeing LUPKYNIS sales at Aurinia. Deja vu anyone? CEO and CCO at HGS got rich, BP got the drug for peanuts and all HGSI investors got f*cked!
View on StockTwits ↗
$AUPH and they were partnered with GSK from the beginning. The problem with $AUPH isn’t PG….it’s time. $HGSI struggled in the beginning and the market was estimated at 7 billion. https://www.reuters.com/article/us-humangenome/human-genome-exploring-options-after-rebuff-of-glaxo-idUSBRE83N19620120424
View on StockTwits ↗
@MZlu @bio99 Not the first time Adam F did bad things to a good biotech company. I remember trading $hgsi when I got into the market first time over 15 years ago.
View on StockTwits ↗
$HGSI (It's a 4h pivot, so we could see higher based on weekly levels). We also thought it possible to reach ~
View on StockTwits ↗
$CLVSQ Human genome sciences $HGSI Was 50 CENTS! then that same year went to $30 https://www.reuters.com/article/humangenome-lupus/preview-big-human-genome-lupus-drug-nears-u-s-market-idUSN078473220110307
View on StockTwits ↗
@JohnnyBanannas With ya on $INDO $MMAT $KAVL $HGSH $HGSI
View on StockTwits ↗$DUO the most recent is just getting started --- it's been beaten down so much -- also $HGSH $HGSI
View on StockTwits ↗$MMAT Add to watchlist -- $RELI.DL0226 has been a scalpers dream. $TLRY is going to blow up this week. I also think China stocks are gonna do well. $HGSI $HGSH
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.